Amidst Rising Overdose Deaths, Policymakers Look for Ways to Expand Access to Proven Opioid Use Disorder Treatment
As the number of opioid-related overdose fatalities remains alarmingly high, access to medication-assisted treatment (MAT) is inconsistent. Private insurance does not always cover the full range of MAT options, and when it does provide coverage cost sharing can be prohibitive. CHIR’s Rachel Swindle takes a look at state and federal reforms that can help lessen private insurance related barriers to treatment.